ProofPilot

Joseph K. is in the spotlight again! 💥 This time, he’s spilling the beans on how ProofPilot’s approach reduces site burden, in an interview with The Clinical Trial Vanguard. In his chat with Moe Alsumidaie, Joe discusses the true root cause of site burden and how we’re reducing it while boosting patient engagement, and making trials easier and more accessible - especially for underserved communities. Big thanks to Clinical Trials Vanguard for helping us tell our story. Read the full article here 🔗 https://lnkd.in/es6C2D6J #ClinicalTrials #ClinicalResearch #PatientEngagement #InclusiveResearch

We're #hiring a new Director of Business Development in United States. Ready to jump into a role where teamwork, big wins, and a fun culture go hand in hand? If you're all about driving results and joining a team that knows how to keep things lively, apply today - or share with your network! 

🎃 Enter the Clinical Trial Chamber of Horrors 🎃 Clinical trials are full of frights 👻 From ghostly participants to haunted protocols, each story we’re sharing captures those spine-chilling “did that just happen?” moments that keep study teams awake at night. 🕯️ Read on... if you dare. 😱 #Halloween #ClinicalTrials #ClinicalResearch #PatientRecruitment #StudyTeam

🔍 In the first two installments of our Data Return Series, we explored what patients want from clinical trials and the ethical imperatives of returning data. Now, it's time to get practical! In our final installment, our Chief Strategy Officer Joseph K. collaborates with Legacy Health Strategies to answer the age-old question: How can Sponsors practically and responsibly return data to participants? 🤔 Here's what you need: ☑️ The essential components of a data return strategy 🌟 Effective ways to engage patients in the process ⚙️ Tools and technologies that streamline data delivery Download the full report 🔗 https://lnkd.in/e8D3ikfn #ClinicalTrials #PatientEngagement #DataReturn #ReturnofResults #PatientCentricity

Imagine you're a patient participating in research, taking a mystery drug, attending 18 - 20 visits, and enduring 34 - 38 procedures (thanks, Tufts Center for the Study of Drug Development, for the eye-opener). And when it ends? Radio silence 😢 For so many people, investing the time, and literally, blood, sweat, and tears, but getting nothing back is frustrating. Patients and their families deserve better. But is there more to this? Might there be an ethical imperative to return information to patients? In Data Return Series - Installment 2, our Chief Strategy Officer Joseph K. joins forces with Legacy Health Strategies to explore: 🔹4 ethical benefits of returning data to patients 🔹4 key areas for responsible data sharing 🔹 4 strategies to align implementation with ethical principles Ready to give back insights, not silence? 👏 Download the full report - link in comments ⬇️ And don't miss out - Data Return Series Part 3 drops tomorrow! #ClinicalTrials #DataReturn #PatientEmpowerment #EthicsInResearch

🤔 Imagine going through an invasive experimental surgery - only to be left wondering, did it work? That's exactly what happened to Emma Yasinski, who, years after her childhood clinical trial, still has no idea of the results. (Her article here: The Outcome of My Clinical Trial Is a Mystery https://lnkd.in/ev4imeBR). The kicker? This issue is too common. According to a 2021 CISCRP study, the majority of participants never hear anything back after a study concludes, let alone their data. 🚫 After nearly a decade since Emma’s story was published, why are we still ghosting patients on trial outcomes? Check out Installment 1 of our Data Return series, authored by our Chief Strategy Officer Joseph K. and Legacy Health Strategies as they shed light on the importance of this in building trust! Check it out now 👉 https://lnkd.in/eDyt9ajV #ClinicalTrials #PatientExperience #ReturnOfResults #DataReturn #TrialOutcome

🌟 Bringing back the spark in clinical trial recruitment! 🌟 We recently explored the often-overlooked challenges of #trialrecruitment during our session at the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit, using a fun twist inspired by the 'Newlywed Game.' 🎮 Just like the game, our panel of experts - comprised of Sponsors from Gilead Sciences, Walgreens Clinical Trials and Takeda and Sites from Javara, Atlas Clinical Research and Lynn Institute - had to guess each others’ answers to the real reasons behind recruitment difficulties. We debunked lots of myths and discovered modern, practical solutions to reignite the connection between Sponsors and Sites!❤️ Read the full blog - 🔗 https://lnkd.in/ejCBAWjN #ClinicalTrials #PatientRecruitment #SCRS #SCRSGlobal

🌟 Did you know we now have a monthly newsletter? 🌟 This is your insider scoop on all things clinical trials - featuring industry news, conference recaps (think #DPHAM #SCRS and more), trends, and insights to keep you in the loop! Stay informed, stay engaged, and enjoy a few laughs along the way! 😄 If you don’t want to experience FOMO, hit subscribe https://hubs.la/Q02Vn4Vb0 #ClinicalTrials #ClinicalResearch #ClinicalDevelopment #PatientRecruitment #ClinOpsNews

Decision-making in clinical trials can be a real minefield.💣 With so many factors at play, what truly makes sites choose one Sponsor over another? How do you elevate yourself to the title of "Sponsor of Choice"? 🔥 At this year’s DPHARM: Disruptive Innovations to Modernize Clinical Research Idol Disrupt, our CEO, Chris Venezia explored these questions. To become the obvious choice for sites, Sponsors must deliver an experience that stands out from the crowd by simplifying the complex and reducing risk. Read the blog for more details! Link in the comments 👇🏼 #ClinicalTrials #ClinicalResearch #SponsorofChoice #DpharmIdol #IdolDisrupt #Dpharm2024

📢 Have you seen our newly revamped Insights section? We’ve made it super easy to explore the content that matters most to you! Now, you can filter by asset type (think whitepapers, case studies, reports) and explores topics like patient recruitment, retention, protocol complexity, data return and more! 🎉 Why wait? Take a tour of our refreshed Insights section now 👉🏼https://hubs.ly/Q02TYN890. #ClinicalTrials #ClinicalTrial #PatientEngagement #PatientRecruitment #PatientRetention #DataReturn